Reviv3 Procare Company
RVIV · OTC
8/31/2025 | 5/31/2025 | 2/28/2025 | 11/30/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.00 | 0.00 | -4.37 | -0.05 |
| FCF Yield | 0.00% | 0.00% | -0.26% | 0.00% |
| EV / EBITDA | -56.74 | 0.00 | 137.83 | 116.72 |
| Quality | ||||
| ROIC | 0.00% | 0.00% | 4.91% | 6.05% |
| Gross Margin | 0.00% | 0.00% | 0.00% | 100.00% |
| Cash Conversion Ratio | -0.29 | 0.96 | -1.17 | 0.84 |
| Growth | ||||
| Revenue 3-Year CAGR | -17.84% | 4.45% | 29.53% | 71.53% |
| Free Cash Flow Growth | 0.00% | 0.00% | 0.00% | 0.00% |
| Safety | ||||
| Net Debt / EBITDA | -56.74 | 0.00 | -6.67 | -7.23 |
| Interest Coverage | 0.00 | 0.00 | 458.78 | -519.19 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 0.00 | 0.00 | 0.00 | 23.64 |